×
About 16,518 results

ALLMedicine™ Acne Center

Research & Reviews  3,434 results

Cushing's syndrome due to ectopic adrenocorticotropin secretion by a parotid carcinoma.
https://doi.org/10.20945/2359-3997000000426
Archives of Endocrinology and Metabolism; Antonacio FF, Harada G et. al.

Jan 15th, 2022 - We report a rare case of Cushing's syndrome in a 37-year-old female who initially presented with localized acinic cell carcinoma of the parotid gland. In January 2014, she underwent a right parotidectomy with facial nerve preservation and adjuvant...

Promising Natural Products in New Drug Design, Development, and Therapy for Skin Disord...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749048
Drug Design, Development and Therapy; Mohd Zaid NA, Sekar M et. al.

Jan 15th, 2022 - The skin is the largest organ in the human body, composed of the epidermis and the dermis. It provides protection and acts as a barrier against external menaces like allergens, chemicals, systemic toxicity, and infectious organisms. Skin disorders...

Effect of Cognitive Behavior Oriented Psychological Intervention on the Psychological S...
https://doi.org/10.1097/SCS.0000000000008448
The Journal of Craniofacial Surgery; Peng Y, Bai Z et. al.

Jan 14th, 2022 - To explore the effect of cognitive behavior oriented psychological intervention on the psychological status of depressed facial acne scar patients receiving fractional photothermolysis. The study enrolled 48 depressed facial acne scar patients who...

Multidrug-resistant Cutibacterium avidum isolated from patients with acne vulgaris and ...
https://doi.org/10.1016/j.jgar.2021.12.021
Journal of Global Antimicrobial Resistance; Koizumi J, Nakase K et. al.

Jan 13th, 2022 - Cutibacterium avidum, a human skin bacterium, rarely causes infectious diseases. It has been recently shown that C. acnes, another member of the genus Cutibacterium, acts as an opportunistic pathogen in surgical site infections. However, the antim...

Adverse Events of Nonablative Lasers and Energy-Based Therapies in Subjects with Fitzpa...
https://doi.org/10.1093/asj/sjab398
Aesthetic Surgery Journal; Hu S, Atmakuri M et. al.

Jan 13th, 2022 - Although there is an abundance of literature on nonablative laser and energy-based therapies for the management of skin conditions, adverse events are inconsistently addressed and range widely across studies. Fitzpatrick skin phototypes (SPTs) IV ...

see more →

Guidelines  7 results

Management of acne vulgaris: summary of NICE guidance.
https://doi.org/10.1136/bmj.n1800
BMJ (Clinical Research Ed.); Xu J, Mavranezouli I et. al.

Sep 22nd, 2021 - Management of acne vulgaris: summary of NICE guidance.|2021|Xu J,Mavranezouli I,Kuznetsov L,Stephen Murphy M,Healy E,|

Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis...
https://www.ncbi.nlm.nih.gov/pubmed/33147660
Dermatology Online Journal; Yim RM, Singh I et. al.

Nov 5th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...

Japanese Dermatological Association Guidelines: Guidelines for the treatment of acne vu...
https://doi.org/10.1111/1346-8138.14355
The Journal of Dermatology; Hayashi N, Akamatsu H et. al.

May 22nd, 2018 - The Guidelines for the Treatment of Acne Vulgaris of the Japanese Dermatological Association was first published in Japanese in 2008 and revised in 2016 and 2017. These guidelines (GL) indicate the standard acne treatments in Japan and address pha...

Management of acne: Canadian clinical practice guideline.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732962
CMAJ : Canadian Medical Association Journal = Journal De ... Asai Y, Baibergenova A et. al.

Nov 18th, 2015 - Management of acne: Canadian clinical practice guideline.|2015|Asai Y,Baibergenova A,Dutil M,Humphrey S,Hull P,|diagnosis,therapy,

Consensus recommendations from the American Acne & Rosacea Society on the management of...
https://www.ncbi.nlm.nih.gov/pubmed/24343208
Cutis Del Rosso JQ, Thiboutot D et. al.

Dec 18th, 2013 - Rosacea is a common clinical diagnosis that encompasses a variety of presentations, predominantly involving the centrofacial skin. Reported to present most commonly in adults of Northern European heritage with fair skin, rosacea can affect males a...

see more →

Drugs  1,884 results see all →

Clinicaltrials.gov  285 results

Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adults
https://clinicaltrials.gov/ct2/show/NCT05080764

Dec 20th, 2021 - The aim of this study is to test the safety and efficacy of photodynamic therapy (PDT) for the medication Ameluz® performed with the PDT-lamp BF-RhodoLED® in comparison to the respective placebo treatment for moderate to severe Acne vulgaris.

A Study of S6G5T3 in the Treatment of Acne Vulgaris
https://clinicaltrials.gov/ct2/show/NCT03761810

Dec 16th, 2021 - In this Phase 3, multi-center, double-blind, randomized, vehicle-controlled, parallel-group pivotal study, participants will be admitted only after a written informed consent has been obtained and after all inclusion/exclusion criteria have been m...

A Study of S6G5T-3 in the Treatment of Acne Vulgaris
https://clinicaltrials.gov/ct2/show/NCT03761784

Dec 16th, 2021 - In this Phase 3, multi-center, double-blind, randomized, vehicle-controlled, parallel-group pivotal study, participants will be admitted only after a written informed consent has been obtained and after all inclusion/exclusion criteria have been m...

A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With Acne Vulgaris
https://clinicaltrials.gov/ct2/show/NCT04856917

Dec 9th, 2021 - This is a Phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Imsidolimab in adolescent and adult subjects with acne vulgaris (AV). This study also will characterize the pharmacokinetic (...

Lactoferrin + Vitamin E + Zinc for Hormonal Acne
https://clinicaltrials.gov/ct2/show/NCT05151055

Dec 9th, 2021 - We previously showed that twice daily intake of a combination of 100 mg lactoferrin, 11 IU vitamin E, and 5 mg zinc significantly reduced both inflammatory and non-inflammatory acne lesions compared to placebo control. In that study, females showe...

see more →

News  962 results

The Leaky Pipeline: A Narrative Review of Diversity in Dermatology
https://www.mdedge.com/dermatology/article/250507/diversity-medicine/leaky-pipeline-narrative-review-diversity-dermatology
Kiyanna Williams, MD, Kanade Shinkai, MD, PhD

Jan 6th, 2022 - With a majority-minority population expected in the United States by 2044, improving diversity and cultural competency in the dermatology workforce is now more important than ever. A more diverse workforce increases the cultural competence of all.

Views and Beliefs of Vitiligo Patients in Online Discussion Forums: A Qualitative Study
https://www.mdedge.com/dermatology/article/250504/pigmentation-disorders/views-and-beliefs-vitiligo-patients-online
Mary Beth Gadarowski, MD, Arjun M. Bashyam, MD et. al.

Jan 6th, 2022 - Vitiligo is a chronic dermatologic condition that negatively affects quality of life (QOL), with substantial burden on the psychosocial well-being of patients. 1 There is no cure, and current treatment modalities are aimed at controlling the chroni.

FDA Approval Sought for Dovitinib for Third-Line Renal Cell Carcinoma
https://www.onclive.com/view/fda-approval-sought-for-dovitinib-for-third-line-renal-cell-carcinoma

Dec 22nd, 2021 - A new drug application (NDA) has been submitted to the FDA seeking the marketing approval of dovitinib as a potential option in the third-line treatment of patients with renal cell carcinoma (RCC), according to an announcement from Allarity Therap...

iPLEDGE Rollout: As Frustration Mounts, FDA Agrees to Help Solve Issues
https://www.medscape.com/viewarticle/965404

Dec 22nd, 2021 - More than a week after the rollout of the new, gender-neutral approach to the risk mitigation program for isotretinoin, frustration and glitches are still an issue, according to dermatologists, pharmacists, and patients. When the new website and c...

Acid series: Azelaic acid
https://www.mdedge.com/dermatology/article/249869/aesthetic-dermatology/acid-series-azelaic-acid
Lily Talakoub, MD, Naissan O. Wesley, MD

Dec 13th, 2021 - Azelaic acid is a bit of a forgotten acid, often in the shadows of glycolic acid and trichloroacetic acid (TCA). However, it has many positive qualities, including being gentle enough to use daily and is safe to use in pregnancy.

see more →

Patient Education  35 results see all →